MedPath

Phase II Dose-ranging Study of APD421 in PONV

Phase 2
Completed
Conditions
Postoperative Nausea and Vomiting
Interventions
Drug: Placebo
Registration Number
NCT01510704
Lead Sponsor
Acacia Pharma Ltd
Brief Summary

To assess the efficacy and safety of different doses of APD421 in the prevention of post-operative nausea and vomiting (PONV) in adult patients at moderate to high-risk of PONV. Patients must be undergoing elective surgery under general anaesthesia (hysterectomy (any surgical technique), cholecystectomy (any surgical technique) or "other" elective surgery scheduled to last at least one hour from induction of anaesthesia), requiring at least one overnight stay in hospital, and have at least 2 of the following risk factors for PONV: Past history of PONV and/or motion sickness; Non-smoking status; Female gender; Planned opiate use for post-operative analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
215
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
Low dose APD421APD4211mg dose level
Mid Dose APD421APD4215mg dose level
High Dose APD421APD42120mg dose level
Primary Outcome Measures
NameTimeMethod
Post-operative Nausea or Vomiting24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

University Hospital

🇫🇷

Nancy, France

Klinikum Ludwigshafen

🇩🇪

Ludwigshafen, Germany

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Hôpital mère enfant

🇫🇷

Bron, France

Hôpital Huriez

🇫🇷

Lille, France

Hôpital FOCH

🇫🇷

Paris, France

Hautepierre Hospital

🇫🇷

Strasbourg, France

Universität Heidelberg

🇩🇪

Heidelberg, Germany

Charité - Universitätsmedizin

🇩🇪

Berlin, Germany

University Hospitals of Würzburg

🇩🇪

Würzburg, Germany

HELIOS Klinikum Aue

🇩🇪

Aue, Germany

Philipps University

🇩🇪

Marburg, Germany

© Copyright 2025. All Rights Reserved by MedPath